Determine the Frequency of a HTPPE in 5 Years (± on 1 Year) After a First Episode of Idiopathic Pulmonary Embolism. (PADIS-HTP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01894204 |
Recruitment Status :
Terminated
(The maximum of inclusions was reached)
First Posted : July 10, 2013
Last Update Posted : July 20, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HTPPE Idiopathic Pulmonary Embolism | Other: HTPPE | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 235 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Frequency and Risk Factors of the Lung High Blood Pressure Post-embolique in the Fall of a First Episode of Idiopathic Pulmonary Embolism. Study " PADIS HTP " |
Actual Study Start Date : | June 27, 2013 |
Actual Primary Completion Date : | May 29, 2018 |
Actual Study Completion Date : | May 29, 2018 |

Arm | Intervention/treatment |
---|---|
HTPPE
No drug and no placebo were used in this study. For all the patients who participated at the study PADIS-EP, somme exams must be performed.
|
Other: HTPPE
No drug and no placebo were used in this study. Some exams must be performed (DLCO - evaluation of the dyspnoea and pulmonary scintigraphy), and in function of the result of the pulmonary scintigraphy, the medical care of the patient will be different : negative pulmonary scintigraphy, stop of the explorations and taken care usual of the patients; positive pulmonary scintigraphy,realisation of a cardiac echography to estimate the presence or not of a not very probable, possible or likely HTP. The indication of the right cardiac catheterization is then put on the combination of the results of the cardiac echography and the evaluation of the dyspnoea. |
- Frequency of a HTPPE [ Time Frame: 24 months ]
- Mortality and cause [ Time Frame: 24 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients having ended the study PADIS EP after the visit of the end of study and having signed the consent HTP.
Exclusion Criteria:
- Refusal to grant in writing to participate in the study PADIS HTP

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01894204
France | |
CHRU de Brest | |
Brest, France, 29609 | |
CHU Clermont-Ferrand | |
Clermont-Ferrand, France, 63003 | |
CH de Lannion | |
Lannion, France, 22300 | |
Hôpital Européen Georges Pompidou | |
Paris cedex 15, France, 75908 | |
CHU Pontchaillou - Hôpital Sud | |
Rennes, France, 35056 | |
Hôpital Yves Le Foll | |
Saint-Brieuc, France, 22027 | |
Hôpital de Bellevue - CHU de Saint-Etienne | |
Saint-Etienne, France, 45055 | |
Hôpital Rangueuil | |
Toulouse, France, 31059 |
Principal Investigator: | Francis COUTURAUD, PU-PH | CHRU de Brest |
Responsible Party: | University Hospital, Brest |
ClinicalTrials.gov Identifier: | NCT01894204 |
Other Study ID Numbers: |
RB 12.161 - PADIS HTP |
First Posted: | July 10, 2013 Key Record Dates |
Last Update Posted: | July 20, 2018 |
Last Verified: | May 2018 |
HTTPE Idiopathic Pulmonary embolism |
Pulmonary Embolism Embolism Embolism and Thrombosis Vascular Diseases |
Cardiovascular Diseases Lung Diseases Respiratory Tract Diseases |